✦ LIBER ✦

Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients

✍ Scribed by Takenaka, Tomoyoshi; Yano, Tokujiro; Kiyohara, Chikako; Miura, Naoko; Kouso, Hidenori; Ohba, Taro; Kometani, Takuro; Shoji, Fumihiro; Yoshino, Ichiro; Maehara, Yoshihiko

Book ID: 119320146
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 453 KB
Volume: 67
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2009.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical expression of excisi

Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

✍ Erdem Cubukcu; Omer Fatıh Olmez; Ozlem Saraydaroglu; Unsal Akcalı; Ozkan Kanat; 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 297 KB

The determination of relationship betwee

The determination of relationship between “excision repair cross-complementing group 1” (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer

✍ Esin Koç; Vildan Caner; Nur Büyükpınarbaşılı; Emre Tepeli; Nilay Şen Türk; G. Oz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 326 KB

Excision repair cross-complementation gr

Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: A review of current literature

✍ Vilmar, Adam; Sørensen, Jens Benn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Excision Repair Cross Complementation Gr

Excision Repair Cross Complementation Group 1 Polymorphisms Predict Overall Survival after Platinum-Based Chemotherapy for Completely Resected Non-Small-Cell Lung Cancer

✍ Katsuhiro Okuda; Hidefumi Sasaki; Yu Hikosaka; Osamu Kawano; Haruhiro Yukiue; Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Excision repair cross-complementation gr

Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy

✍ Koichi Azuma; Yoshihiro Komohara; Tetsuro Sasada; Yasuhiro Terazaki; Jiro Ikeda; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Response to gemcitabine–platinum chemoth

Response to gemcitabine–platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer

✍ In-Jae Oh; Hee-Jung Ban; Kyu-Sik Kim; Sang-Yun Song; Kook-Joo Na; Yun-Hyeon Kim; 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 163 KB